AntimetabolitesAntimetabolites, AntineoplasticAntineoplastic Combined Chemotherapy ProtocolsTetrahydrouridinePyrimidinesFloxuridineTrabeculectomyMethotrexate6-MercaptopurinePyrimidine NucleotidesFluorouracilPyrimidine DimersAntineoplastic AgentsCytarabineMitomycinSurgical SpongesDeoxycytidineLeukemia L1210DoxorubicinChemotherapy, AdjuvantThioguaninePyrimidine NucleosidesCyclophosphamideInosine MonophosphatePhosphoribosyl PyrophosphateVidarabine Phosphate6-AminonicotinamideDrug SynergismPurinesNeoplasmsCombined Modality TherapyFolic Acid AntagonistsTumor Cells, CulturedEtoposidePantothenic AcidCell SurvivalCisplatinNorleucineTreatment OutcomeDrug Screening Assays, AntitumorCell DivisionVinblastineThymidylate SynthasePhosphonoacetic AcidBleomycinAntineoplastic Agents, PhytogenicLomustineDisease-Free SurvivalGuanineDrug Administration ScheduleCell LineSurvival AnalysisAzathioprineNeoplasm StagingSurvival RateDrug Evaluation, PreclinicalLymphoma, Non-HodgkinNeoadjuvant TherapyPrognosisDeoxyribonuclease (Pyrimidine Dimer)Vinca AlkaloidsIfosfamidePyrimidine PhosphorylasesDrug Resistance, NeoplasmLung NeoplasmsCell CycleBreast NeoplasmsUracilKineticsOrotic AcidPaclitaxelCarboplatinDaunorubicinStreptomycesAntibodies, Monoclonal, Murine-DerivedOrotate PhosphoribosyltransferaseHodgkin DiseaseP-GlycoproteinUltraviolet RaysNeoplasm Recurrence, LocalDrug ResistanceApoptosisDacarbazineAsparaginaseMelphalanLymphoma, Large B-Cell, DiffusePrednisolonePrecursor Cell Lymphoblastic Leukemia-LymphomaDrug Resistance, MultipleAntibiotics, AntineoplasticInduction ChemotherapyDihydroorotaseDeoxyribodipyrimidine Photo-LyaseTime FactorsLeukemia P388Dose-Response Relationship, DrugAntineoplastic Agents, AlkylatingFollow-Up StudiesCarmustineTaxoids